Cargando…

Neuroprotective effects of ATPase inhibitory factor 1 preventing mitochondrial dysfunction in Parkinson's disease

Mitochondrial dysfunction is a key element in the progression of Parkinson’s disease (PD). The inefficient operation of the electron transport chain (ETC) impairs energy production and enhances the generation of oxidative stress contributing to the loss of dopaminergic cells in the brain. ATPase inh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, InHyeok, Park, Han-A, Kang, Jun, Kim, Heyyoung, Hah, Su Min, Lee, Juhee, Kim, Hyeon Soo, Choi, Won-Seok, Chung, Ji Hyung, Shin, Min-Jeong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907304/ https://www.ncbi.nlm.nih.gov/pubmed/35264673 http://dx.doi.org/10.1038/s41598-022-07851-8

Ejemplares similares

Author Correction: Neuroprotective effects of ATPase inhibitory factor 1 preventing mitochondrial dysfunction in Parkinson's disease
por: Chung, InHyeok, et al.
Publicado: (2022)

Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection
por: Mounsey, Ross B., et al.
Publicado: (2010)

Oxidative Stress, Mitochondrial Dysfunction, and Neuroprotection of Polyphenols with Respect to Resveratrol in Parkinson’s Disease
por: Kung, Heng-Chung, et al.
Publicado: (2021)

Neuroprotective Effect of Nortriptyline in Overt Hepatic Encephalopathy Through Attenuation of Mitochondrial Dysfunction
por: Jeong, Ji Heun, et al.
Publicado: (2018)

Inhibitory Effect of Astaxanthin on Oxidative Stress-Induced Mitochondrial Dysfunction-A Mini-Review
por: Kim, Suhn Hyung, et al.
Publicado: (2018)

Neuroprotective effects of 20(S)-protopanaxadiol against glutamate-induced mitochondrial dysfunction in PC12 cells
por: BAK, DONG-HO, et al.
Publicado: (2016)

The Multifaceted ATPase Inhibitory Factor 1 (IF1) in Energy Metabolism Reprogramming and Mitochondrial Dysfunction: A New Player in Age-Associated Disorders?
por: Gore, Emilia, et al.
Publicado: (2022)

Neuroprotective Effects of Cuscutae Semen in a Mouse Model of Parkinson's Disease
por: Ye, Minsook, et al.
Publicado: (2014)

Mitochondrial Dysfunction in Parkinson's Disease
por: Keane, P. C., et al.
Publicado: (2011)

Mitochondrial Dysfunction in Parkinson's Disease
por: Moon, Hyo Eun, et al.
Publicado: (2015)

Mitochondrial dysfunction in Parkinson’s disease
por: Hu, Qingsong, et al.
Publicado: (2016)

Mitochondrial Metabolism as Target of the Neuroprotective Role of Erythropoietin in Parkinson’s Disease
por: Rey, Federica, et al.
Publicado: (2021)

Irisin exhibits neuroprotection by preventing mitochondrial damage in Parkinson’s disease
por: Zhang, Xi, et al.
Publicado: (2023)

Generation of mitochondrial reactive oxygen species is controlled by ATPase inhibitory factor 1 and regulates cognition
por: Esparza-Moltó, Pau B., et al.
Publicado: (2021)

Molecular mechanism on forcible ejection of ATPase inhibitory factor 1 from mitochondrial ATP synthase
por: Kobayashi, Ryohei, et al.
Publicado: (2023)

Amyloid‐β activates NLRP3 inflammasomes by affecting microglial immunometabolism through the Syk‐AMPK pathway
por: Jung, Eun Sun, et al.
Publicado: (2022)

Validity and Reliability of the Korean Version of the Parkinson’s Disease Questionnaire–Carer
por: Lee, JuHee, et al.
Publicado: (2023)

SELF-CARE AND QUALITY OF LIFE IN PEOPLE WITH PARKINSON’S DISEASE AND THEIR CAREGIVERS
por: Kim, Eunyoung, et al.
Publicado: (2022)

Neuroprotective Function of Fucoxanthin in Oxidative Stress-Mediated Mitochondrial Dysfunction
por: Ferdous, Khondoker Adeba, et al.
Publicado: (2022)

Protective effects of PEP-1-Catalase on stress-induced cellular toxicity and MPTP-induced Parkinson’s disease
por: Eom, Seon Ae, et al.
Publicado: (2015)

Upregulation of mitochondrial ATPase inhibitory factor 1 (ATPIF1) mediates increased glycolysis in mouse hearts
por: Zhou, Bo, et al.
Publicado: (2022)

Mitochondrial therapy for Parkinson’s disease: Neuroprotective pharmaconutrition may be disease-modifying
por: Kones, Richard
Publicado: (2010)

Carnitine acetyltransferase deficiency mediates mitochondrial dysfunction‐induced cellular senescence in dermal fibroblasts
por: Song, Min Ji, et al.
Publicado: (2023)

Mitochondrial Dysfunction in Parkinson’s Disease: Focus on Mitochondrial DNA
por: Buneeva, Olga, et al.
Publicado: (2020)

Inhibitory to non-inhibitory evolution of the ζ subunit of the F(1)F(O)-ATPase of Paracoccus denitrificans and α-proteobacteria as related to mitochondrial endosymbiosis
por: Mendoza-Hoffmann, Francisco, et al.
Publicado: (2023)

Dietary Antioxidants and the Mitochondrial Quality Control: Their Potential Roles in Parkinson’s Disease Treatment
por: Lee, Davin, et al.
Publicado: (2020)

Inhibitory Effects of Laminaria japonica Fucoidans Against Noroviruses
por: Kim, Hyojin, et al.
Publicado: (2020)

A novel splicing variant of DJ-1 in Parkinson's disease induces mitochondrial dysfunction
por: Cho, Namjoon, et al.
Publicado: (2023)

Incidence of and risk factors for thyroid dysfunction during peginterferon α and ribavirin treatment in patients with chronic hepatitis C
por: Hwang, Yong, et al.
Publicado: (2015)

Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson’s disease
por: Bido, Simone, et al.
Publicado: (2017)

Plasma membrane calcium ATPase regulates bone mass by fine-tuning osteoclast differentiation and survival
por: Kim, Hyung Joon, et al.
Publicado: (2012)

Kinetic analysis of the inhibition mechanism of bovine mitochondrial F(1)-ATPase inhibitory protein using biochemical assay
por: Kobayashi, Ryohei, et al.
Publicado: (2021)

Inhibitory Activities of Dimeric Ellagitannins Isolated from Cornus alba on Benign Prostatic Hypertrophy
por: Park, Dong-Hui, et al.
Publicado: (2021)

Mitochondrial Dysfunction as a Novel Target for Neuroprotective Nutraceuticals in Ocular Diseases
por: Huang, Chun-Ping, et al.
Publicado: (2020)

Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction
por: Tribble, James R., et al.
Publicado: (2021)

BAPTA, a calcium chelator, neuroprotects injured neurons in vitro and promotes motor recovery after spinal cord transection in vivo
por: Kang, Kyu‐ree, et al.
Publicado: (2021)

In Vitro and in Vivo Neuroprotective Effects of Walnut (Juglandis Semen) in Models of Parkinson’s Disease
por: Choi, Jin Gyu, et al.
Publicado: (2016)

Microgravity induces autophagy via mitochondrial dysfunction in human Hodgkin’s lymphoma cells
por: Jeong, Ae Jin, et al.
Publicado: (2018)

Mitochondrial Dysfunction of Immortalized Human Adipose Tissue-Derived Mesenchymal Stromal Cells from Patients with Parkinson's Disease
por: Moon, Hyo Eun, et al.
Publicado: (2013)

p66shc siRNA Nanoparticles Ameliorate Chondrocytic Mitochondrial Dysfunction in Osteoarthritis
por: Shin, Hyo Jung, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bca024mrun16cf2gdb5ibh0c8t